Business
Envoy Medical Regains Compliance with Nasdaq Listing Requirement
White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has evidenced compliance with Nasdaq Listing Rule 5550(b)(2) through the alternatives permitted under Listing Rule 5550(b).As previously disclosed, the Company..
About this update from Envoy Medical, Inc.
[{"type":"text","content":"White Bear Lake, Minnesota--(Newsfile Corp. - February 24, 2026) - Envoy Medical® Inc. (NASDAQ: COCH) ("Envoy Medical" or the "Company"), a hearing health company pioneering fully implanted hearing solutions, today announced that it has received written notification from The Nasdaq Stock Market LLC ("Nasdaq") confirming that the Company has evidenced compliance with Nasdaq Listing Rule 5550(b)(2) through the alternatives permitted under Listing Rule 5550(b).","length":492,"tagName":"p"},{"type":"text","content":"As previously disclosed, the Company received a notice from Nasdaq on February 25, 2025, indicating that it was not in compliance with the continued listing requirement to maintain a minimum Market Value of Listed Securities (MVLS) of $35 million. The Company subsequently implemented strategic financing initiatives and substantially strengthened its balance sheet, resulting in regaining compliance with the applicable continuing listing requirement.","length":452,"tagName":"p"},{"type":"text","content":"The Company believes it has an achievable plan to maintain compliance and looks forward to remaining listed on the Nasdaq Capital Market under the symbol "COCH."","length":171,"tagName":"p"},{"type":"text","content":"To be added to the Envoy Medical email distribution list, please email [email protected] with COCH in the subject line.","length":116,"tagName":"p"},{"type":"text","content":"About Envoy Medical, Inc.","length":25,"tagName":"p"},{"type":"text","content":"Envoy Medical (NASDAQ: COCH) is a hearing health company focused on providing innovative technologies across the hearing loss spectrum. Envoy Medical has pioneered one-of-a-kind, fully implanted devices for hearing loss, including its fully implanted Esteem® active middle ear implant, commercially available in the U.S. since 2010, and the fully implanted Acclaim® cochlear implant, an investigational device. Envoy Medical is dedicated to pushing hearing technology beyond the status quo to improve access, usability, compliance, and ultimately quality of life.","length":563,"tagName":"p"},{"type":"text","content":"About the Fully Implanted Acclaim® Cochlear Implant","length":51,"tagName":"p"},{"type":"text","content":"We believe the fully implanted Acclaim Cochlear Implant ("Acclaim CI") is a first-of-its-kind hearin...